RESMED INC — Director's Dealing 2011

Jan 7, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2011-01-05

Reporting Person: Gallahue Kieran (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-01-05	ResMed Common Stock	M	32590	$21.025	Acquired	89511.794	Direct
2011-01-05	ResMed Common Stock	S	32590	$35.06	Disposed	56921.794	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-01-05	ResMed Common Stock Options	$21.025	M	32590	Disposed	2014-11-07	ResMed Common Stock (32590)	Direct

Footnotes

F1: Represents first date options became exercisable.